{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Nintedanib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Nintedanib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Nintedanib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "nintedanib",
    "trial_2_text": "Nintedanib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Nintedanib Supplement: 60 participants will take Nintedanib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Nintedanib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Nintedanib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.3901834189891815,
      "78": 0.33286839723587036,
      "67": 0.20171299576759338,
      "46": 0.1624445766210556,
      "64": 0.14605535566806793,
      "17": 0.14461162686347961,
      "123": 0.14417041838169098,
      "189": 0.1428658813238144,
      "37": 0.1420845091342926,
      "9": 0.13702934980392456,
      "68": 0.13678473234176636,
      "173": 0.13572829961776733,
      "20": 0.12724901735782623,
      "49": 0.12497369199991226,
      "188": 0.12387924641370773,
      "228": 0.12206611782312393,
      "2": 0.11883983016014099,
      "21": 0.11471830308437347,
      "177": 0.10623503476381302,
      "396": 0.10508320480585098,
      "200": 0.09756429493427277,
      "204": 0.09406028687953949,
      "77": 0.09265987575054169,
      "350": 0.09196602553129196,
      "14": 0.09034817665815353,
      "126": 0.08900993317365646,
      "101": 0.08218034356832504,
      "18": 0.0810551568865776,
      "79": 0.07987494021654129,
      "339": 0.07935131341218948,
      "131": 0.0782795399427414,
      "257": 0.07714615762233734,
      "5": 0.07691740244626999,
      "4": 0.07300177216529846,
      "147": 0.0716930627822876,
      "104": 0.07069508731365204,
      "72": 0.06981144845485687,
      "116": 0.06895628571510315,
      "61": 0.06891252100467682,
      "193": 0.06841564178466797,
      "139": 0.0679144412279129,
      "243": 0.06757958233356476,
      "151": 0.06693071871995926,
      "239": 0.06647874414920807,
      "191": 0.06601189076900482,
      "382": 0.06583958119153976,
      "130": 0.06534956395626068,
      "114": 0.06520804762840271,
      "38": 0.06508222967386246,
      "29": 0.06466643512248993,
      "30": 0.06223492696881294,
      "136": 0.06191129609942436,
      "76": 0.061892665922641754,
      "85": 0.06062181293964386,
      "28": 0.060528114438056946,
      "441": 0.06040600314736366,
      "276": 0.05806037038564682,
      "261": 0.055920396000146866,
      "124": 0.05536673590540886,
      "234": 0.055011115968227386,
      "82": 0.054533544927835464,
      "286": 0.05440335348248482,
      "86": 0.053343772888183594,
      "142": 0.05328111723065376,
      "122": 0.05319799482822418,
      "194": 0.05296774208545685,
      "269": 0.05256154015660286,
      "454": 0.051109809428453445,
      "356": 0.05016201362013817,
      "33": 0.04866914451122284,
      "337": 0.047600157558918,
      "75": 0.046628307551145554,
      "179": 0.045642394572496414,
      "138": 0.045500628650188446,
      "121": 0.04523438215255737,
      "180": 0.044926468282938004,
      "186": 0.04388173669576645,
      "27": 0.04234384745359421,
      "163": 0.042098771780729294,
      "96": 0.041780028492212296,
      "97": 0.041707735508680344,
      "211": 0.04167523607611656,
      "36": 0.04129139706492424,
      "292": 0.040205202996730804,
      "288": 0.04009401798248291,
      "144": 0.0397716723382473,
      "11": 0.03970939293503761,
      "69": 0.0395892858505249,
      "35": 0.038520701229572296,
      "15": 0.03832745552062988,
      "249": 0.03827428072690964,
      "422": 0.038063470274209976,
      "31": 0.03721882402896881,
      "100": 0.0369228832423687,
      "355": 0.035268012434244156,
      "92": 0.03508477658033371,
      "218": 0.03503863885998726,
      "118": 0.034864723682403564,
      "747": 0.03485223650932312,
      "466": 0.03483090177178383
    },
    "trial_2_ae": {
      "87": 0.3901834189891815,
      "78": 0.33286839723587036,
      "67": 0.20171299576759338,
      "46": 0.1624445766210556,
      "64": 0.14605535566806793,
      "17": 0.14461162686347961,
      "123": 0.14417041838169098,
      "189": 0.1428658813238144,
      "37": 0.1420845091342926,
      "9": 0.13702934980392456,
      "68": 0.13678473234176636,
      "173": 0.13572829961776733,
      "20": 0.12724901735782623,
      "49": 0.12497369199991226,
      "188": 0.12387924641370773,
      "228": 0.12206611782312393,
      "2": 0.11883983016014099,
      "21": 0.11471830308437347,
      "177": 0.10623503476381302,
      "396": 0.10508320480585098,
      "200": 0.09756429493427277,
      "204": 0.09406028687953949,
      "77": 0.09265987575054169,
      "350": 0.09196602553129196,
      "14": 0.09034817665815353,
      "126": 0.08900993317365646,
      "101": 0.08218034356832504,
      "18": 0.0810551568865776,
      "79": 0.07987494021654129,
      "339": 0.07935131341218948,
      "131": 0.0782795399427414,
      "257": 0.07714615762233734,
      "5": 0.07691740244626999,
      "4": 0.07300177216529846,
      "147": 0.0716930627822876,
      "104": 0.07069508731365204,
      "72": 0.06981144845485687,
      "116": 0.06895628571510315,
      "61": 0.06891252100467682,
      "193": 0.06841564178466797,
      "139": 0.0679144412279129,
      "243": 0.06757958233356476,
      "151": 0.06693071871995926,
      "239": 0.06647874414920807,
      "191": 0.06601189076900482,
      "382": 0.06583958119153976,
      "130": 0.06534956395626068,
      "114": 0.06520804762840271,
      "38": 0.06508222967386246,
      "29": 0.06466643512248993,
      "30": 0.06223492696881294,
      "136": 0.06191129609942436,
      "76": 0.061892665922641754,
      "85": 0.06062181293964386,
      "28": 0.060528114438056946,
      "441": 0.06040600314736366,
      "276": 0.05806037038564682,
      "261": 0.055920396000146866,
      "124": 0.05536673590540886,
      "234": 0.055011115968227386,
      "82": 0.054533544927835464,
      "286": 0.05440335348248482,
      "86": 0.053343772888183594,
      "142": 0.05328111723065376,
      "122": 0.05319799482822418,
      "194": 0.05296774208545685,
      "269": 0.05256154015660286,
      "454": 0.051109809428453445,
      "356": 0.05016201362013817,
      "33": 0.04866914451122284,
      "337": 0.047600157558918,
      "75": 0.046628307551145554,
      "179": 0.045642394572496414,
      "138": 0.045500628650188446,
      "121": 0.04523438215255737,
      "180": 0.044926468282938004,
      "186": 0.04388173669576645,
      "27": 0.04234384745359421,
      "163": 0.042098771780729294,
      "96": 0.041780028492212296,
      "97": 0.041707735508680344,
      "211": 0.04167523607611656,
      "36": 0.04129139706492424,
      "292": 0.040205202996730804,
      "288": 0.04009401798248291,
      "144": 0.0397716723382473,
      "11": 0.03970939293503761,
      "69": 0.0395892858505249,
      "35": 0.038520701229572296,
      "15": 0.03832745552062988,
      "249": 0.03827428072690964,
      "422": 0.038063470274209976,
      "31": 0.03721882402896881,
      "100": 0.0369228832423687,
      "355": 0.035268012434244156,
      "92": 0.03508477658033371,
      "218": 0.03503863885998726,
      "118": 0.034864723682403564,
      "747": 0.03485223650932312,
      "466": 0.03483090177178383
    }
  },
  "safety": {
    "trial_1_safety": 0.3111719787120819,
    "trial_2_safety": 0.3111719787120819
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47666457295417786
  }
}